Lataa...
Inhibition of the PI3K/Akt signaling pathway reverses sorafenib-derived chemo-resistance in hepatocellular carcinoma
Long-term sorafenib treatment triggers resistance to chemotherapy in patients with hepatocellular carcinoma (HCC). In order to investigate the mechanisms of sorafenib resistance in HCC, the aim of the present study was to develop a resistant human liver cell line via long-term exposure to sorafenib....
Tallennettuna:
| Julkaisussa: | Oncol Lett |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6004698/ https://ncbi.nlm.nih.gov/pubmed/29928334 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8536 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|